Streetbeat News

Stock Prices

BC

Brunswick Corporation (BC) has lowered its FY2024 outlook, adjusting its EPS from $7.00-$8.00 to $5.00-$5.50 and sales from $5.20B-$5.40B, significantly below the estimated $7.15 and $5.97B respectively. The company also provided updated guidance on net sales, free cash flow, and share repurchases.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:19 am

TER

Teradyne shares are trading lower following soft Q3 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:19 am

NOW

ServiceNow shares are trading higher after the company reported better-than-expected Q2 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:18 am

STLA

Stellantis shares are trading lower following the release of their H1 financial results.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:18 am

STM

STMicroelectronics shares are trading lower after the company reported a Q2 EPS miss and issued soft Q3 guidance.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:17 am

PCG

PG&E has provided its 2024 non-GAAP core EPS guidance, estimating it to be between $1.33 and $1.37, compared to the analyst estimate of $1.36.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:17 am

BC

Brunswick (NYSE:BC) reported Q2 2024 earnings of $1.80 per share, missing the analyst estimate of $1.90. Sales were $1.443 billion, also below the $1.553 billion estimate. Both earnings and sales showed significant declines from the same period last year.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:16 am

XPRO

Expro Group has raised its FY2024 sales guidance from $1.60B-$1.70B to $1.70B-$1.75B, surpassing the $1.67B estimate. The company also refined its Adjusted EBITDA guidance to $350M-$375M. Third quarter revenue is expected to be $410M-$430M, with a sequential decrease but year-on-year growth of 14%.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:13 am

F

Ford shares are trading lower following a Q2 EPS miss.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:13 am

EW

Edwards Lifesciences shares are trading lower after the company reported worse-than-expected Q2 sales results and issued Q3 guidance below estimates. Additionally, the company acquired JenaValve and Endotronix.

Portfolio Pulse from Benzinga Newsdesk

July 25, 2024 | 10:13 am